Osteoarthritis Treatment Patent

Stempeutics has been granted a US patent for the treatment of osteoarthritis using *Stempeucel-OA*. This patent is a significant development for the millions of people in India living with knee osteoarthritis. The condition can cause severe pain and disability. Key points of this development include:
- The US Patent and Trademark Office has granted US Patent No to Stempeutics for this innovative treatment
- *Stempeucel-OA* is a novel treatment option for osteoarthritis
- The patent grant is a major milestone for Stempeutics